Tulip Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.70 Cr
as on 08-07-2024
- Paid Up Capital ₹ 1.70 Cr
as on 08-07-2024
- Company Age 19 Year, 4 Months
- Last Filing with ROC 31 Mar 2015
- Open Charges ₹ 4.25 Cr
as on 08-07-2024
- Satisfied Charges ₹ 2.43 Cr
as on 08-07-2024
About Tulip Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2015. It's a company limited by shares with an authorized capital of Rs 1.70 Cr and a paid-up capital of Rs 1.70 Cr.
The company currently has active open charges totaling ₹4.25 Cr. The company has closed loans amounting to ₹2.43 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jagjit Chahal and Paramjit Singh serve as directors at the Company.
- CIN/LLPIN
U24230HP2005PTC028713
- Company No.
028713
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jul 2005
- Date of AGM
30 Sep 2015
- Date of Balance Sheet
31 Mar 2015
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Kangra, Himachal Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Tulip Formulations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagjit Chahal  | Director | 02-Jul-2011 | Current |
| Paramjit Singh | Director | 02-Jul-2011 | Current |
Financial Performance of Tulip Formulations.
Enhance accessibility to Tulip Formulations's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Tulip Formulations?
Unlock access to Tulip Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Chahal Tyreworld Private LimitedActive 23 years 5 monthsJagjit Chahal and Paramjit Singh are mutual person
- New Piyar Roadways Private LimitedActive 27 years 4 months
Jagjit Chahal and Paramjit Singh are mutual person
- Mbp Pharmaceuticals Private LimitedActive 17 years 11 months
Jagjit Chahal and Paramjit Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 23 Mar 2012 | ₹4.25 Cr | Open |
State Bank Of Patiala Creation Date: 12 Apr 2007 | ₹2.43 Cr | Satisfied |
How Many Employees Work at Tulip Formulations?
Tulip Formulations has a workforce of 5 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tulip Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tulip Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
